Gynefam supra allaitement
Food supplement declared in France, declaration No 2022-3-26
Gynefam supra allaitement, from EFFIK, is a food supplement declared in France. Status: withdrawn from the market on 21 March 2025. Main ingredients: Nicotinic acid (vitamin B3), Pantothenic acid (vitamin B5), Biotin (vitamin B8), Calcium, Copper. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- gynefam
- Food business operator placing the product on the market
- EFFIK
- Status
- Withdrawn from the market on 21 March 2025
- Form
- Capsule
- Daily dose
- 2 capsules
- Directions for use
- Prendre 2 capsules par jour avec un grand verre d'eau
- Intended populations
- Women
- Not recommended (according to the manufacturer)
- Taking thyroid medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Pregnancy and breastfeeding
Declaration 214868, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Huile de poisson | not declared |
| Taurine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| nicotinic acid | Nicotinic acid (vitamin B3) | 10 mg | 8 mg |
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| calcium carbonate | Calcium | 2,500 mg | 800 mg |
| calcium salts of orthophosphoric acid | Calcium | 2,500 mg | 800 mg |
| cupric sulphate | Copper | 5,000 µg | 2,000 µg |
| ferrous bisglycinate | Iron | 40 mg (safe level) | 14 mg |
| (6S)-5-methyltetrahydrofolic acid, glucosamine salt | Folate (vitamin B9) | 1,000 µg | 200 µg |
| potassium iodate | Iodine | 600 µg | 150 µg |
| sodium selenite | Selenium | 255 µg | 50 µg |
| retinyl palmitate | Vitamin A | 3,000 µg d'équivalent rétinol | 800 µg |
| thiamin mononitrate | Vitamin B1 (thiamine) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| cyanocobalamin | Vitamin B12 | no adverse effect defined | dose annulled by the French Council of State in 2011 |
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
| DL-alpha-tocopheryl acetate | Vitamin E | 300 mg | 30 mg |
| zinc oxide | Zinc | 25 mg | 15 mg |
Additives
E422, E322, E172, E420
Other ingredients
gélatine, Huile de carthame
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Déconseillé aux personnes souffrant de troubles de la thyroïde ou de maladies ayant pour conséquence une accumulation anormale de fer. A éviter en cas d'allergie connue à l'un des composants.Consultez votre médecin, votre sage-femme ou votre pharmacien avant de prendre ce complément alimentaire.Complément alimentaire à consommer dans le cadre d'un mode de vie sain. il ne doit pas être utilisé comme substitut d'un régime alimentaire varié et équilibré. Tenir hors de la vue et de la portée des jeunes enfants. A conserver dans un endroit frais et sec, à l'abri de la lumière.
Regulatory points
- Information
Withdrawn from the market on 21 March 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : gynefam
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Gynefam supra allaitement: composition and regulation”, https://compoatlas.com/en/supplements/products/214868-gynefam-supra-allaitement, updated 15 November 2026.